In a previously reported study, we used a standard metamorphosis anuran model to assess potential effect of the antibacterial agent triclosan (TCS) on normal prometamorphic Xenopus laevis. Results indicated that environmentally relevant TCS concentrations did not alter the normal course of thyroidmediated metamorphosis in this standard anuran model. However, to examine potential effects of TCS exposure during premetamorphosis and to distinguish between effects on metamorphosis and effects on growth, a longer term TCS exposure study was conducted. Standard Nieuwkoop and Faber (NF) stage 47 X. laevis larvae were exposed for 32 days (ca. NF stage 59-60) via flow-through to four different concentrations of TCS: < 0.2 (control), 0.8, 3.1, 12.5, or 50.0 mg TCS/l. Primary endpoints were survival, hind limb length, body length (whole; snout-to-vent), developmental stage, wet whole body weight, thyroid histology, plasma thyroid hormone (TH) concentrations, TH receptor beta (TRb), and type II and III deiodinase (DI-2 and DI-3) expression. Endpoints measured to evaluate effects on thyroid-mediated metamorphosis including developmental stage, thyroid histology, TRb expression, DI-2 and DI-3 expression, and thyroid gland 3,5,3#,5#-tetraiodothyronine (T4) and plasma T4 and 3,5,3#-triiodothyronine (T3) levels were not affected by TCS exposure. However, increased larval growth based on whole body length (0.78, 12.5, and 50 mg TCS/l), snout-vent length (3.1 and 12.5 mg TCS/l), and whole body weight (0.8, 12.5, and 50.0 mg TCS/l) was observed following 32-day TCS exposure. These results indicated that TCS exposure during pre-and prometamorphosis increased larval growth but did not alter the normal course of metamorphosis in X. laevis. The increased growth associated with TCS exposure was not unexpected and is generally consistent with the presence of reduced bacterial stressors in culture.
In a previously reported study, we used a standard metamorphosis anuran model to assess potential effect of the antibacterial agent triclosan (TCS) on normal prometamorphic Xenopus laevis. Results indicated that environmentally relevant TCS concentrations did not alter the normal course of thyroidmediated metamorphosis in this standard anuran model. However, to examine potential effects of TCS exposure during premetamorphosis and to distinguish between effects on metamorphosis and effects on growth, a longer term TCS exposure study was conducted. Standard Nieuwkoop and Faber (NF) stage 47 X. laevis larvae were exposed for 32 days (ca. NF stage 59-60) via flow-through to four different concentrations of TCS: < 0.2 (control), 0.8, 3.1, 12.5, or 50.0 mg TCS/l. Primary endpoints were survival, hind limb length, body length (whole; snout-to-vent), developmental stage, wet whole body weight, thyroid histology, plasma thyroid hormone (TH) concentrations, TH receptor beta (TRb), and type II and III deiodinase (DI-2 and DI-3) expression. Endpoints measured to evaluate effects on thyroid-mediated metamorphosis including developmental stage, thyroid histology, TRb expression, DI-2 and DI-3 expression, and thyroid gland 3,5,3#,5#-tetraiodothyronine (T4) and plasma T4 and 3,5,3#-triiodothyronine (T3) levels were not affected by TCS exposure. However, increased larval growth based on whole body length (0.78, 12.5, and 50 mg TCS/l), snout-vent length (3.1 and 12.5 mg TCS/l), and whole body weight (0.8, 12.5, and 50.0 mg TCS/l) was observed following 32-day TCS exposure. These results indicated that TCS exposure during pre-and prometamorphosis increased larval growth but did not alter the normal course of metamorphosis in X. laevis. The increased growth associated with TCS exposure was not unexpected and is generally consistent with the presence of reduced bacterial stressors in culture.
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The thyroid gland in most amphibians develops during late embryogenesis (Dodd and Dodd, 1976; Regard, 1978) . In Xenopus laevis, the thyroid develops from a thickening of the pharyngeal epithelium around Nieuwkoop and Faber (NF) stage 35 (hatching) (Nieuwkoop and Faber, 1994) . Following division of the thyroid, follicular development is present by NF stage 44. A functional thyroid gland with approximately 20 follicles is present by NF stage 53. As the prometamorphosed larvae mature, follicular development continues, resulting in growth of the gland. Concurrently, thyroid hormone (TH) synthesis and secretion into the circulatory system increases in preparation for metamorphosis. After metamorphosis is complete, the thyroid gland regresses in size, which may be responsible for the reduced levels of circulating TH after metamorphosis is complete. Two naturally occurring THs, 3,5,3#,5#-tetraiodothyronine (T4) and 3,5,3#-triiodothyronine (T3) have been identified. Based on years of experimental evidence, there is little question today concerning the causative effect of TH on amphibian metamorphosis (Allen, 1929 (Allen, , 1916 Brown et al., 1995; Dodd and Dodd, 1976; Gudernatsch, 1912; Leloup and Buscagalia, 1977; Tata, 1968; White and Nicoll, 1981) . Three primary morphological changes occur during anuran metamorphosis: (1) resorption or regression of tissue or organ systems that have primary function only in the larval life stage; (2) the remodeling of larval organ systems to their adult form, which are suitable only for the adult; and (3) de novo development of tissues in the adult that are not required by the larvae.
Pharmaceutical and personal care products (PPCPs) are potential sources of xenobiotics found in both aquatic and terrestrial environments (Kolpin et al., 2002) . Triclosan (TCS) (5-chloro-2-[2,4-dichlorophenoxy] phenol) is a broad-spectrum antimicrobial used in a variety of over-the-counter drug products, which include antigingivitis toothpaste, antibacterial hand soaps, first aid antiseptics, as well as in personal care products such as deodorants. Down-the-drain consumer waste is the primary source of TCS in the environment, as municipal wastewater treatment facilities (WWTFs) removed at least 70% as the result of biodegradation and 20-25% due to physical sorption (Bester, 2005 (Bester, , 2003 Heidler and Halden, 2006; Sabaliunas et al., 2003; Singer et al., 2002; Thompson et al., 2005; Waltman et al., 2006) . Recently, Bock et al. (2010) evaluated the fate and partitioning of TCS in WWTFs using a probabilistic fugacity model. This model predicted that 84-92% of TCS is removed by WWTFs with 40% removed due to physical sorption and 48% due to biodegradation. TCS levels measured in surface water generally range from 0.1 to 0.7 lg TCS/l (Bester, 2005 To date, studies examining the potential endocrine-disrupting capacity of TCS in aquatic organisms have been less than conclusive. Foran et al. (2000) evaluated the effects of TCS exposure on Oryzias latipes (medaka) development, concluding that TCS was not estrogenic but potentially weakly androgenic. However, these conclusions were based solely on nonsignificant changes in gender ratios and fin length. Ishibashi et al. (2004) reported weak vitellogenin induction in male medaka and X. laevis exposed to TCS, suggesting a weak estrogenic response.
Structural similarities in TCS and TH have prompted further investigation into potential thyroid axis disruption capacity of TCS (Crofton et al., 2007; Veldhoen et al., 2006) . Veldhoen et al. (2006) suggested that TCS was capable of modulating THdependent gene expression and disrupting postembryonic Rana catesbeiana (bullfrog) development. Several studies have been conducted to evaluate whether TCS affects TH homeostasis via downstream mechanisms. Hanioka et al. (1996) and Jinno et al. (1997) found that TCS induced cytochrome P-450 2B1/2 and hepatic ethoxy-resorufin-O-deethylase and pentoxy-resorufin-Odeethylase activity. Schuur et al. (1998) determined that TCS inhibited iodothyronine sulfonation in rats in vitro. TCS has also been shown to inhibit 3-phosphoadenosine 5-phosphosulfatesulfotransferase and UDP glucuronosyltransferase in human liver fractions (Wang et al., 2004) . Most recently, You (2004) found that TCS induced glucuronidase activity, which is important in maintaining TH homeostasis (Capen, 1994; DeVito et al., 1999) .
Based on the indication that TCS could disturb thyroid axis function, leading to altered metamorphosis in amphibians, further evaluation of the effects of TCS on anuran metamorphosis in the standard model, X. laevis, was performed (Fort et al., 2010) . Because the studies by Veldhoen et al. (2006) used a premetamorphic model, which was not actively engaged in metamorphosis, the study by Fort et al. (2010) was conducted using a prometamorphic model to determine if a similar response occurred during metamorphosis. The study by Fort et al. (2010) was critically reviewed by Helbing et al. (2011) with response by Fort et al. (2011) . Prometamorphosis refers to the stages of development in which active metamorphosis occurs prior to metamorphic climax, whereas premetamorphosis refers to the larval stages prior to the onset of prometamorphosis. Results from the initial prometamorphic study (Fort et al., 2010) indicated that environmentally relevant TCS concentrations did not alter the normal course of thyroidmediated metamorphosis in prometamorphic X. laevis exposed to TCS for 21 days. However, to examine potential effects of TCS exposure during premetamorphosis (stages prior to the onset of active metamorphosis) a 32-day study was conducted using NF stage 47 larvae. The study was performed to further evaluate and confirm potential effects of TCS on anuran metamorphosis and distinguish between effects on metamorphosis from effects on growth. The primary endpoints were hind limb length, body length (whole and snout-to-vent [SVL]), developmental stage, wet weight, thyroid histology, and daily measure of mortality. In addition, whole thyroid tissue and plasma samples were collected for endogenous TH (thyroxine [T4] and triiodothyronine [T3]) analysis. Hind limb (deiodinase) and tail fin tissue samples were collected during the exposure to measure effects on TH receptor beta (TRb) and type II and III deiodinase (DI-2 and DI-3) expression. Results from these studies are presented in this report.
MATERIALS AND METHODS

Materials
Triclosan. The test chemical, TCS, lot number 60240CL5, was provided by Ciba, Inc., now part of BASF (Basel, Switzerland) and was used throughout the study. TCS was > 99.9% pure, as confirmed by the Certificate of Analysis.
Stock solution preparation and test concentrations. A working stock solution of TCS was used to prepare the test concentrations. The stock solution was prepared in a 19-l glass carboy by dissolving TCS in approximately 4 l of dilution water at 50°C using a hot plate and high-capacity top stirrer. After cooling, the carboy was topped off with dilution water to a total volume of 18 l. Based on the previous 21-day exposure study (Fort et al., 2010) , the same target concentrations were used: control (< 0.2), 0.8, 3.1, 12.5, and 50.0 lg/l TCS.
Culture (dilution) water and laboratory control. Dechlorinated (charcoal filtered) tap water was used as culture or dilution water. The dechlorinated laboratory water was prepared by passing tap water through a four-filter system; a multimedia filter to remove suspended solids in the feed water; a 10$ pretreatment filter (5 lm) to remove any additional solids; a 3.6 cf activated virgin carbon treatment filter to remove chlorine, ammonia, and higher molecular weight organics; and a 5-lm polishing filter to remove any carbon particles from the carbon treatment phase. The dechlorinated tap water also served as the laboratory control water. The temperature, pH, and dissolved oxygen (DO) of the culture water were monitored daily during testing. Other culture water quality characteristics measured at least once during the 32-day study were conductivity, hardness, alkalinity, ammonia-nitrogen, and residual oxidants. Trace contaminants, to include organics (volatile and semivolatile) and inorganics (metals, nitrates/nitrites, fluoride, and iodide), were analyzed annually.
Test Animal
The test species for this study was the South African Clawed Frog (X. laevis), from which NF stage 47 larvae were used in the metamorphosis assay.
Culture and animal husbandry. The X. laevis larvae used for this study were obtained from an in-house culture (originally purchased from Xenopus I,
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Dexter, MI) where adults were injected with human chorionic gonadotropin to induce reproduction. All larvae that were used as test organisms were derived from the same clutch (spawn). The embryos were held at 21°C ± 1°C for 4 days to allow for hatching and development to NF stage 47.
Feeding. Larvae were fed Sera Micron (Sera GmbH, Heinsberg, Germany) throughout the preexposure period (after NF stage 45/46) and during the entire test period of 32 days. Sera Micron, a commercially available tadpole food that has been shown to support proper growth and development of X. laevis larvae, is a fine particulate that stays suspended in the water column for a long period of time and is subject to washing out with the flow. Therefore, the total daily amount of food was divided into smaller portions and fed twice daily. Initially, 300 mg Sera Micron per tank was fed twice per day (total ¼ 600 mg/day) for the first week of exposure. During the course of the study, the total daily food ration was increased approximately 15% per week to accommodate larval growth. Feeding was continued at a frequency of twice per day on Monday through Friday and once per day at twice the volume on weekends. Sera Micron was fed as a stock solution and freshly prepared in the laboratory every other day at a confirmed density of 60 mg Sera Micron/ml dilution water.
Exposure System
The route of TCS exposure was abiotic via culture media, which is the most appropriate method for aquatic organisms and readily water soluble test materials. A flow-through diluter system (Benoit Mini-Diluter; Environmental Consulting and Testing, Superior, WI) was used in the performance of the amphibian metamorphosis assay exposure (Benoit et al., 1982) . The system consisted of water contact components of glass (aquaria), stainless steel (diluter housing and water bath), and Teflon (tubing responsible for test material delivery). Exposure tanks were glass aquaria (with approximate measurements of 22.5 3 14.0 3 16.5 cm deep) equipped with standpipes that resulted in an actual tank volume of 4.0 l and minimum water depth of 10-15 cm. The system was capable of supporting five exposure concentrations and a control, with up to four replicates per treatment. The flow rate to each tank was 25 ml/min, which provided a complete volume replacement every 2.7 h. Fluorescent lighting was used to provide a photoperiod of 12 h light and 12 h dark at an intensity that ranged from 600 to 1000 lux (lumens/m 2 ) at the water surface. Water temperature was maintained at 21°C ± 1°C, pH maintained between 6.5 and 8.5, and the DO concentration > 3.5 mg/l (> 40% of air saturation) in each test chamber.
Chemical Analysis
Temperature, pH, DO, and light intensity were measured daily to monitor diluter system performance. The solubility, purity, and stability (volatility and degradation rate) of TCS were determined prior to starting the in-life assay. Based on this information, the frequency of preparation of fresh stock solutions was determined. Exposure concentrations were also analyzed from treatment samples collected from the mini-diluter at test startup, at least weekly thereafter, and at test takedown. TCS analysis of the test solutions and stock solutions was performed using liquid chromatography-mass spectrometry (LC-MS) with isotope dilution (Agilent 1100 high performance liquid chromatography [HPLC] with API 4000 Triple Quadrupole MS).
Test solutions from each concentration were sampled for TCS during the diluter system equilibration phase, at in-life study day 0, approximately once per week during in-life study, and at test termination. In addition, each new stock solution was sampled and analyzed for TCS. Immediately following collection, the pH in all test solutions was adjusted to < 2.0 with phosphoric acid, spiked with a 13 C 6 -TCS internal standard (10 ng/ll in methanol) (Ciba, Inc.), and stored at 4°C. Due to the biodegradability of TCS in aqueous conditions, analysis was performed as soon as possible following collection. Samples of the TCS test concentrations were extracted with methanol (1:1 [vol/ vol] ) and analyzed by LC-MS. The stock solution extracts were diluted 1:100 (vol/vol) and analyzed by LC-MS.
A Phenomex Synergy Max RP 75 3 2 mm (4 lm particle) HPLC column was used with a flow rate of 300 ll/min at room temperature. The eluents consisted of water with 0.1% (vol/vol) formic acid (A) and methanol (B). The MS source was Turbulon Spray in negative mode with an MS/MS multiple reaction monitoring scan at IS: À4200 V, temperature: 450°C, EP: À10, and dwell time: 100 ms. The mean percent recovery of TCS from spiked analytical reference samples was 89.6 ± 3.8%.
Test Animal Selection
When a sufficient number of the preexposure population of X. laevis reached developmental stage 47 (5-7 days posthatch at 21°C ± 1°C), larvae were transferred to a pooling tank containing dilution water. Individual larvae were randomly removed from the pooling tank by scooping with a small strainer and anesthetized in a transparent chamber (e.g., 100 mm Petri dish containing 100 mg of tricaine methanesulfonate [MS-222]/l dilution water buffered with 200 mg/l of sodium bicarbonate). Animals were carefully handled during this transfer in order to minimize handling stress and to avoid injury.
The developmental stage of the animals was then determined by using a binocular dissection microscope. In order to reduce the ultimate variability in developmental stage, it is important that this staging be conducted as accurately as possible. The primary developmental landmark for selecting NF stage 47 organisms is the presence of the hind limb bud (Nieuwkoop and Faber, 1994) . The morphological characteristics of the hind limbs were examined under the microscope.
Larvae that met the stage criterion were transferred to a holding tank containing 100% culture (dilution) water and allowed to recover from the anesthesia. After recovery, the selected larvae were randomly distributed (no more than 80 per treatment) to exposure treatment tanks containing 4.0 l treatment solution until each tank contained 20 larvae (five larvae per liter density). Each treatment tank was then inspected for animals with abnormal appearance (e.g., injuries, abnormal swimming behavior, etc.). Overtly unhealthy appearing larvae were removed from the treatment tanks and replaced with larvae newly selected from the holding tank at test initiation. Treatment tanks were properly labeled and randomly assigned to a position in the exposure system in order to account for possible variations in temperature and light intensity.
Test Method
The randomly selected NF stage 47 larvae were exposed to four test concentrations and a dilution water control. Each test concentration and control was evaluated in quadruplicate, with 20 organisms per replicate. Once larvae were placed in the exposure system, mortality observations were made daily and any dead larvae were immediately removed. On day 12, five larvae randomly selected per replicate were anesthetized in MS-222, plasma collected for T3 and T4 analyses, thyroid glands collected for T4 analysis, hind limbs collected for deiodinase activity, and tails collected for TRb gene expression measurements. The test was terminated on day 32, at which time all test animals were anesthetized in MS-222, staged for development, weighed, digitally photographed for measurement, and visually observed for dysmorphology. Larvae were randomly selected (five per replicate), euthanized, and reserved for possible histology. An additional five anesthetized larvae were randomly selected from the remaining animals in each replicate treatment (100 animals) for blood serum and thyroid gland tissue collection for T3 and T4 analyses and tail tissue for TRb and deiodinase gene expression measurements. Critical test parameters and experimental conditions for the in-life study are presented in Table 1 .
Biological Endpoints
The primary endpoints of the metamorphosis assay were mortality, developmental stage (NF), growth (determined by length and weight), and thyroid histology. Gross morphology (physical appearance at test takedown) was a secondary endpoint. In addition, whole thyroid tissue and serum samples were collected at test termination for analysis of endogenous T3 (serum only) and T4. Tail biopsies were collected for measurement of TRb, DI-2, and DI-3 expression. Table 1 provides an overview of the measurement endpoints and the corresponding observation time points.
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tank. Dead animals were removed from the test tank as soon as observed. The developmental stage of X. laevis larvae were determined using generally accepted staging criteria from Nieuwkoop and Faber (1994) . Differentiation of the hind limbs is under control of THs and are major developmental landmarks already used in the determination of developmental stage. Hind limb development was used qualitatively in the determination of developmental stage but was considered as a quantitative endpoint in the present study by normalizing hind limb length to SVL. Therefore, hind limb length was measured as an endpoint to detect effects on the thyroid axis. All length measurements were based on digital photographs of the organisms from each treatment. Two different approaches to assess larval growth were used: (1) measurement of whole body length and (2) measurement of SVL. Both length parameters were assessed to produce a solid database for a comparison concerning their utility to reflect changes in larval growth.
Determinations of wet body weight were used to assess possible effects of TCS on the growth rate of larvae in comparison to the control group. Although measurements of larval wet weight may provide a more precise estimation of larvae growth, weight determinations during the course of the study would be technically more difficult to obtain. Compared with length measurements, the removal of adherent water for weight determinations could cause more stressful conditions for larvae, including possible skin damage. Therefore, wet weight measurements were only performed on day 12 subsamples prior to tissue sampling and on all remaining larvae at test termination (day 32).
Although developmental stage and hind limb length are important endpoints to evaluate exposure-related changes in metamorphic development, developmental delay cannot, by itself, be considered a diagnostic indicator of thyroid axis modulation. Some changes may only be observable by routine histopathological analysis. In summary, developmental stage and hind limb length endpoints were used as morphological measures of metamorphosis, whereas whole body length, SVL, and wet whole body weight endpoints were used as a morphological measure of growth.
Biochemical and gene expression endpoints. T4 and more specifically T3 control metamorphic processes in amphibians, including X. laevis. Blood and thyroid gland tissue samples were collected at days 12 and 32 for T3 and T4 analyses. TH was measured by using newly customized ELISA kits from GenWay (San Diego, CA). Samples were collected for T3 and T4 analyses at exposure day 12 and at test conclusion. Plasma was collected via aortic Measurement of TRb and peripheral deiodinase expression during metamorphosis represents a downstream biomarker of thyroid axis activity at a molecular level. TRb expression has been used as an early indicator of disruption of metamorphic events in amphibians and the thyroid axis. Measurement of DI-2 assists in evaluation of the conversion of T4 to the more potent metamorphic inducers T3 in the tissues. Measurement of DI-3 represents a means of evaluating the deactivation of THs by the conversion of T3 to diiodothyronine and the conversion of T4 to reverse T4. Tissue samples at exposure days 0, 12, and 32 were collected for examination of TRb and deiodinase expression, respectively.
PCR methodologies for specifically measuring TRb (Fort et al., 2010; Veldhoen and Helbing, 2001 ) and deiodinase (Dubois et al., 2006; Lehigh Shirey et al., 2006) gene expression changes, as the result of exposure to potential endocrine-disrupting chemicals in X. laevis hind limb and tail biopsies, were used. Tissue samples were preserved in RNAlater (Ambion, Inc., Austin, TX) prior to gene expression analysis. Each biopsy was homogenized in 300 ll TRIzol using a Brinkman Polytron microhomogenizer (Fisher Scientific, Houston, TX) and total RNA isolated, resuspended in RNase-free water (Invitrogen, Burlington, Ontario), and stored at À80°C prior to complementary (cDNA) preparation. A 20-lg sample of glycogen was added during RNA isolation to maximize RNA recovery (Zhang et al., 2006) . The isolated RNA (1.0 lg) from each sample was annealed with 500 ng of random hexamer oligonucleotide and cDNA produced with Superscript II reverse transcriptase (Invitrogen) in accordance with manufacturer specifications. The produced cDNA was diluted at least 25-fold prior to amplification.
PCR amplification was performed using a Mini-Opticon system (BioRad, Hercules, CA) with TRb-and deiodinase-specific primers (Invitrogen) in accordance with manufacturer's recommendations and Fort et al. (2010) . Amplified DNA products were separated on a 2% agarose gel, visualized by ethidium bromide staining on a Chemi-Imager 4000 (Alpha InnoTech, San Leandro, CA), and quantified by accompanying software. Amplifications were optimized to a linear range of detection. Furthermore, densitometric data were normalized to control gene, ribosomal protein L8 (rpL8), which is a suitable marker of integrity.
Thyroid morphometric endpoints. Measurement of various thyroid gland measurements was made following the termination of exposure on day 32. Measurements including thyroid area, follicle count, follicular cell height, follicular area, colloid content per specimen, and colloid content per follicle were collected to further evaluate potential effect of TCS exposure on thyroid gland function and assist in separating growth effects from developmental effects on metamorphosis.
Thyroid pathology. The heads of stage-matched NF 59 larvae were cut from the body in a transverse plane just caudal to the eyes. Decalcification was not necessary to remove bone at the time of gross trimming. The head was processed using an automatic tissue processor and then embedded in paraffin with the cut side down. Rough bilateral sections were made until the thyroid glands were observed. When the thyroid glands were reached, three 32-lm step sections were made and the step sections were mounted on a slide. The slides were then stained with hematoxylin and eosin. The histopathological evaluation of the thyroid glands included review of potential changes in the glands as hypertrophy of follicular cells, hyperplasia of thyroid follicles, size of thyroid follicles, and degree of colloid accumulation in the thyroid follicles, a qualitative assessment as to size of the thyroid gland.
Data Analysis
With the exception of developmental stage data, apical morphology endpoints were analyzed using one-way ANOVA (parametric data sets) or Kruskal-Wallis (KW) ANOVA on ranks (nonparametric data sets) accompanied by appropriate post hoc comparison tests (p ¼ 0.05). Statistical evaluation of frequency distributions of developmental stages in the control and treatments was performed using a Mann-Whitney U-test (p ¼ 0.05) as described by Fort et al. (2011) and USEPA (2009). The 5th and 95th percentiles for median developmental stage data sets were also determined and reported.
RESULTS
TCS Measurement
Measured TCS concentrations of the control and each test concentration (target concentration in parenthesis) were < 0.2 (below detection limit) lg/l (control), 0.3 (0.78), 1.3 (3.1), 5.9 (12.5), and 29.6 (50.0) lg/l, reported as time-weighted average concentrations based on eight sampling events per test concentration during the 32-day test period (Tables 2-5).
Control
A summary of morphological endpoint data for the dilution water control is presented in Table 2 . During the 32-day exposure period initiated at NF stage 47, the mean control survival frequency was 100% and the median control NF developmental stage was 60 (Table 2) . Developmental stage distribution, whole body, hind limb and snout-vent lengths, and whole body weight were consistent with historical control data (Fort et al., 2010) (Table 2 ). Control larvae thyroid gland histology appeared normal (Table 4) .
TCS Treatments
Mortality. Negligible mortality was observed during the test and ranged from 0.0% in the control and 1.3, 5.9, and 29.6 lg/l TCS treatments to 1.3% in the 0.3 lg/l TCS treatment (Table 2) .
Developmental stage. The median developmental stages obtained for the control, 0.3, 1.3, 5.9, and 29.6 lg/l TCS measured treatments following 32 days of TCS exposure were NF stages 60, 59, 59, 59, and 59, respectively (Table 2) . Overall, the frequencies of developmental stage obtained following 32 days of exposure to TCS in each of the treatment concentrations were not different from control (Mann-Whitney U, p > 0.05). SVL normalized hind limb lengths in each of the treatment concentrations were not significantly different from the control (ANOVA, p ¼ 0.192).
Growth. Mean whole body length, snout-vent length, and whole body weight data for day 32 are provided in Table 2 . Whole body length and weight of larvae exposed to 0.3, 5.9, and 29.6 lg/l TCS were significantly greater than the laboratory control (KW-ANOVA, Dunn's method, p < 0.05 and ANOVA, Bonferroni t-test, p 0.001, < 0.001, and 0.004, respectively). Mean SVLs of larvae exposed to the 1.3 and 5.9 lg/l TCS were significantly greater than control larvae (KW-ANOVA, Dunn's method, p < 0.05).
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Gross morphology. Examination of terminal stage larvae did not reveal grossly observable changes, indicating no external adverse effects from exposure to the study chemical concentrations.
Thyroid pathology. None of the specimens examined from the control treatments displayed abnormal thyroid gland histology (Table 3) . A TCS concentration-related increase in the occurrence of minimal thyroid gland hypertrophy and minimal thyroid gland vascular congestion was observed. Diagnosis of minimal gland hypertrophy was based on visual inspection with peer review suggesting that the thyroid glands were generally larger than found in control specimens. The increase in thyroid gland size was accompanied by the The 5th and 95th percentiles for the median stage data are report below each median in parenthesis. Reported values are based on means of eight sampling events per concentration with SEM. Test concentrations measured as less than method detection limit (MDL, 0.2 lg/l) were reported as half the MDL (0.1 lg/l) for calculation purposes.
b Diagnosis of gland hypertrophy was based on visual inspection with peer review suggesting that the thyroid glands were generally larger than found in control specimens (see Table 4 ). The increase in thyroid gland size was accompanied by the observation that the larger glands contained larger follicles and an increased number of follicles per gland. The increase in gland and follicle size was not accompanied by follicular hypertrophy or hyperplasia. The lack of follicular hypertrophy or hyperplasia was suggested to be the result of both the minimal nature of the response and the increased body size of the treated specimens. Further examinations of the relationship between specimen growth and thyroid gland size and physiology are provided in Tables 4 and 5. c Vascular congestion was characterized by the presence of dilated blood vessels within the interstitium of the thyroid glands. Because a co-occurrence of vascular congestion and thyroid hypertrophy occurred, thyroid gland enlargement could not be attributed to increased vascularization and appeared to be a function of the size of specimens examined.
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observation that the larger glands contained larger follicles and an increased number of follicles per glands. The increase in gland and follicle size was not accompanied by follicular hypertrophy or hyperplasia. The lack of follicular hypertrophy or hyperplasia was suggested to be the result of both the minimal nature of the response and the increased body size of the treated specimens. Vascular congestion was characterized by the presence of dilated blood vessels within the interstitium of the thyroid glands. Because a co-occurrence of vascular congestion and thyroid hypertrophy occurred, thyroid gland enlargement could not be attributed to increased vascularization and appeared to be a function of the size of specimens examined. Photomicrographs of bilateral thyroid sections from control and 29.6 lg/l TCS-treated larvae documenting the normalcy of the thyroid glands are provided in Figures 1a and 2c. TH analysis. No detectable plasma THs (< 0.02 lg/dl T4 and < 0.4 lg/dl T3) were measured at exposure day 12 (ca. NF stage 51). Results of analysis of T4 in thyroid glands and T3 and T4 in plasma samples collected on exposure day 32 from stage-matched laboratory control and TCS-treated larvae are presented in Figures 3a and 3b , respectively. Lower serum T4, but not T3, levels in samples collected from the 0. TRb and deiodinase expression. Evaluation of TRb and DI-2 and DI-3 expression in hind limb (exposure day 12 DI only) and tail fin biopsies from stage-matched TCS exposure day 12 and day 32 specimens relative laboratory control larvae is presented in Figures 4a and 4b , respectively. No effect of TCS exposure on TRb (ANOVA, p ¼ 0.881) and DI-2 and DI-3 (KW-ANOVA, p ¼ 0.936 and 0.240) expression in exposure day 12 specimens was observed in tail (TRb) and hind limb (deiodinase) tissues relative to the control. In addition, no changes in either TRb (ANOVA, p ¼ 0.196) or deiodinase (KW-ANOVA, p ¼ 0.265 and 0.386, respectively) expression in tail fin tissue were noted in biopsies collected from the TCS treatments at exposure day 32 relative to the control.
Thyroid gland metrics and relationship to larval growth. A quantitative evaluation of the thyroid glands in control and TCS-treated specimens was performed to evaluate the relationship between thyroid gland size and anatomical/physiological characteristics and larval growth. A summary of exposure day 32 thyroid gland analytical measurements is provided in Table  4 . Based on this examination, the mean thyroid gland size of larvae exposed to 0.3, 5.9, and 29.6 (ANOVA, Bonferroni ttest, p ¼ 0.015, 0.001, and 0.043) lg/l TCS, but not the 1. 
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(ANOVA, Bonferroni t-test, p ¼ 0.053) lg/l TCS-treated larvae, was significantly larger than glands from control specimens. No differences in the number of follicles (ANOVA, p ¼ 0.267), mean follicle size (KW-ANOVA, p ¼ 0.235), mean colloid content per animal (KW-ANOVA, p ¼ 0.521), and mean colloid content per follicle (KW-ANOVA, p ¼ 0.850) were found between the TCS-treated larvae and control larvae. Mean follicular cell height decreased (1.3, 5.9, and 29.6 lg/l TCS) with increasing TCS concentration (KW-ANOVA, Dunn's test, p < 0.05). Because no change in epithelial cell shape or structure was noted, changes in follicular cell height were attributed to growth.
Multiple comparison correlation analysis of thyroid gland measurements and growth parameters is provided in Table 5 . The only positive correlation between growth endpoints and analytical measurement of thyroid anatomy/physiology was mean thyroid area and whole body length (Pearson correlation, r 2 ¼ 0.77, p ¼ 0.037). A negative correlation between mean follicular cell height and mean SVL was detected (Pearson correlation, r 2 ¼ À0.99, p ¼ 0.002), but this relationship was not detected with the other measures of growth. None of the analytical measures of thyroid function (physiology), such as the number of follicles, follicle size, and most importantly colloid per animal and colloid per follicle, were correlated with larval growth. These results suggested that the slightly increased size of the thyroid gland, decreasing follicular cell height, and increased vascularization associated with increasing TCS exposure concentration were simply a function of increased growth and not a direct effect on the thyroid gland.
DISCUSSION
Anuran metamorphosis is separated into three distinct periods: premetamorphosis, prometamorphosis, and metamorphic climax. Premetamorphosis refers to a period of embryonic and early larvae development that takes place without TH. Some advanced morphological developments occur during this stage including hind limb bud development. More specific morphogenesis, such as differentiation of the digits and rapid growth (elongation) of the hind limbs, occurs during prometamorphosis. Biochemically, prometamorphosis is Note. Hypothesis testing was performed using Pearson product moment correlation, p > 0.050. The top number is the correlation coefficient, and the bottom number is the p value. The pairs of variables with positive correlation coefficients and p values below 0.050 tend to increase together. For the pairs with negative correlation coefficients and p values below 0.050, one variable tends to decrease, whereas the other increases. For pairs with p values greater than 0.050, no significant relationship between the two variables exists. Values in bold represent a significant positive or negative correlation between the two associated variables. 300 FORT ET AL. characterized by rising concentrations of endogenous TH. The final period is metamorphic climax, in which a surge of TH triggers the final processes associated with metamorphosis, including forelimb development and resorption of the tail. Drastic internal transformations at the organ system, tissue, and biochemical levels are also taking place during prometamorphosis and metamorphic climax.
The thyroid axis represents one potential target for environmental chemicals. Environmental agents, toxicants, natural products, and complex mixtures can alter metamorphosis by interacting with the thyroid axis. Furthermore, the complexity of the thyroid axis yields many different possible mechanisms of inhibiting metamorphic processes in amphibians at differing biochemical and molecular levels. Thus, the use of amphibians as representatives of the chordates to screen for thyroid-disrupting chemicals or chemical mixtures is not unreasonable.
In the present study, significant differences in developmental stages between the laboratory control and the TCS treatments were not observed, no adverse effects on thyroid histology were detected, and no changes in either thyroid gland T4 or serum T3 and T4 levels were found. In addition, no changes in TRb or DI-2 and DI-3 expression in tail tissue collected from exposure day 32 larvae or hind limb (deiodinase) and tail (TRb) tissue collected from exposure day 12 larvae exposed to TCS were noted in this study in relation to control specimens. Exposure to TCS did increase larval growth and generally increased the overall size and vasculature of the thyroid glands in the higher TCS concentrations. However, the general increase in thyroid gland size was related to increased growth in the TCS treatments. Not surprisingly, the increase in growth observed was greater in the 32-day pre-/prometamorphosis exposure than in original studies using 21-day prometamorphosis exposure format (Fort et al., 2010) . Previous studies (Fort et al., 2010 and Fort and Rogers, unpublished data) found that antibiotic (penicillin/streptomycin) treatment of X. laevis larvae during premetamorphic development slightly increased larval growth, but exposure during prometamorphosis did not increase metamorphic rate, cause histopathological changes in the thyroid gland, alter serum or thyroid gland T4 levels, or markedly alter TRb expression. Thus, the antibiotic/antibacterial agents studied appear to marginally accelerate premetamorphic growth by a nonthyroidal process but do not alter the process of metamorphosis in X. laevis. The increased growth associated with TCS exposure was not unexpected and is generally consistent with the antimicrobial activity of TCS in culture (Calabrese, 2008; Fort et al., 2010) .
Because the Endocrine Disruptor Screening and Testing program administered by the USEPA requires the use of a 21-day exposure Amphibian Metamorphosis Assay (frog) (USEPA, 2009), the importance of distinguishing between effects on larval growth and effects on metamorphosis should not be underestimated. Differentiating between the two effects essentially determines if the test substance is endocrine active within the thyroid axis in the case of metamorphosis or potentially acts by a nonendocrine mode of action in the case of growth. The inability to separate effects on amphibian metamorphosis from growth effects leads to the potential for falsely identifying thyroid-disrupting chemicals. In the case of TCS, effects on whole body length, SVL, and whole (wet) body weight, but not hind limb length, plasma THs, thyroid gland THs, and TRb and deiodinase expression, clearly indicated that TCS altered growth, but not thyroid-mediated metamorphosis. In addition, further quantitative examination of the thyroid gland was required to confirm that the subtle effects on the thyroid were actually the result of increased growth. Overall, this study demonstrated that significant professional judgment may be required in evaluating results from amphibian metamorphosis studies.
In conclusion, the present study provided evidence that TCS does not alter the normal course of metamorphosis in the standard anuran model, X. laevis, at the test concentrations studied. Based on the battery of endpoints used in this study, the no observed adverse effect concentration for disruption of thyroid-driven metamorphosis was 29.6 lg/l TCS. However, TCS exposure to X. laevis tadpoles during development was capable of increasing growth. The effects on growth appeared to be the result of nonthyroidal mechanisms and were generally consistent with the presence of reduced bacterial stressors in culture. 
